ANGN logo

Angion Biomedica (ANGN) EBITDA

Annual EBITDA

-$29.45 M
+$9.06 M+23.53%

December 31, 2022


Summary


Performance

ANGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherANGNprofitabilitymetrics:

Quarterly EBITDA

-$4.56 M
-$895.00 K-24.43%

March 31, 2023


Summary


Performance

ANGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherANGNprofitabilitymetrics:

TTM EBITDA

-$22.99 M
+$9.70 M+29.67%

March 31, 2023


Summary


Performance

ANGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherANGNprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ANGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.5%+68.0%+30.3%
3 y3 years+22.7%+63.2%+13.1%
5 y5 years-105.3%+67.6%-63.5%

ANGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+30.8%-130.7%+212.7%+62.3%+67.5%
5 y5-yearat high+85.6%-130.7%+334.0%+63.5%+191.7%
alltimeall time-1281.0%+85.6%-130.7%+334.0%-1470.2%+191.7%

Angion Biomedica EBITDA History

DateAnnualQuarterlyTTM
Mar 2023
-
-$4.56 M(+24.4%)
-$22.99 M(-29.7%)
Dec 2022
-$29.45 M(-23.5%)
-$3.66 M(-38.6%)
-$32.69 M(+130.7%)
Sep 2022
-
-$5.96 M(-32.3%)
-$14.17 M(-40.3%)
Jun 2022
-
-$8.80 M(-38.3%)
-$23.74 M(-28.0%)
Mar 2022
-
-$14.26 M(-196.0%)
-$32.98 M(-14.4%)
Dec 2021
-$38.51 M(-29.5%)
$14.86 M(-195.6%)
-$38.51 M(-42.6%)
Sep 2021
-
-$15.54 M(-13.8%)
-$67.07 M(+6.5%)
Jun 2021
-
-$18.04 M(-8.8%)
-$62.97 M(+1.5%)
Mar 2021
-
-$19.78 M(+44.4%)
-$62.03 M(+13.5%)
Dec 2020
-$54.65 M
-$13.70 M(+19.7%)
-$54.65 M(-0.6%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$11.44 M(-33.1%)
-$55.00 M(+26.3%)
Jun 2020
-
-$17.10 M(+37.9%)
-$43.55 M(+64.6%)
Mar 2020
-
-$12.40 M(-11.8%)
-$26.46 M(+88.2%)
Dec 2019
-$38.09 M(+165.7%)
-$14.06 M(<-9900.0%)
-$14.06 M(-5904.3%)
Dec 2018
-$14.34 M(-675.2%)
-
-
Jun 2014
-
$124.50 K(+5.8%)
$242.20 K(-79.9%)
Mar 2014
-
$117.70 K(-89.2%)
$1.21 M(-28.1%)
Dec 2013
$2.49 M(+26.9%)
-
-
Jun 2013
-
$1.09 M(+84.4%)
$1.68 M(+184.4%)
Mar 2013
-
$590.00 K
$590.00 K
Dec 2012
$1.96 M
-
-

FAQ

  • What is Angion Biomedica annual EBITDA?
  • What is the all time high annual EBITDA for Angion Biomedica?
  • What is Angion Biomedica annual EBITDA year-on-year change?
  • What is Angion Biomedica quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Angion Biomedica?
  • What is Angion Biomedica quarterly EBITDA year-on-year change?
  • What is Angion Biomedica TTM EBITDA?
  • What is the all time high TTM EBITDA for Angion Biomedica?
  • What is Angion Biomedica TTM EBITDA year-on-year change?

What is Angion Biomedica annual EBITDA?

The current annual EBITDA of ANGN is -$29.45 M

What is the all time high annual EBITDA for Angion Biomedica?

Angion Biomedica all-time high annual EBITDA is $2.49 M

What is Angion Biomedica annual EBITDA year-on-year change?

Over the past year, ANGN annual EBITDA has changed by +$9.06 M (+23.53%)

What is Angion Biomedica quarterly EBITDA?

The current quarterly EBITDA of ANGN is -$4.56 M

What is the all time high quarterly EBITDA for Angion Biomedica?

Angion Biomedica all-time high quarterly EBITDA is $14.86 M

What is Angion Biomedica quarterly EBITDA year-on-year change?

Over the past year, ANGN quarterly EBITDA has changed by +$9.70 M (+68.02%)

What is Angion Biomedica TTM EBITDA?

The current TTM EBITDA of ANGN is -$22.99 M

What is the all time high TTM EBITDA for Angion Biomedica?

Angion Biomedica all-time high TTM EBITDA is $1.68 M

What is Angion Biomedica TTM EBITDA year-on-year change?

Over the past year, ANGN TTM EBITDA has changed by +$9.99 M (+30.29%)